bioRxiv
DLL3 expression predicts response and long-term outcome in small cell lung cancer patients treated with tarlatamab
Preprint: trial in peopleBiomarkers
The paper
The University of Texas MD Anderson Cancer Center
bioRxiv, 7 Sep 2026, Preprint, not peer-reviewed

